New Sofia Fund Kansas City partner Laura McCoolidge, on convertible notes
https://www.startlandnews.com/2019/09/fundraising-for-real-convertible-notes/…
Sofia Fund
CogRX Gains Patent Coverage in Japan and China
Portfolio company CogRX gains patent coverage in Japan and China for Elayta, Cognition’s lead drug for treatment of mild to moderate Alzheimer’s disease.
Joylux, Adds Prominent Oncologist and Former FDA Commissioner to Advisory Board
Sofia Fund portfolio company, Joylux, announces they have raised more than $9M exclusively through prominent angel investors and angel groups including the Sofia Fund and has expanded their Advisory Board by adding Dr. Michael Friedman, former FDA Commissioner.
Sofia Fund is a National Go-to Resource
Sofia Fund is a national go-to resource for what’s happening in the Midwest startup community. See ABC News story here.…
Cognition Therapeutics Receives $3.3 Million NIA Grant to Conduct qEEG Study of Elayta™ with World-Leading Alzheimer’s Biomarker Experts
Investigating Quantitative EEG as Biomarker of Patient Response to Treatment in Future Efficacy Studies
Pittsburgh, PA, July 09, 2019 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the protection and restoration of synaptic function in Alzheimer’s disease and other neurodegenerative disorders, today announced the receipt of a grant expected to total $3.3 million from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to conduct a clinical trial (COG0202) in which quantitative electroencephalography (qEEG) will be used to measure changes in synaptic activity in individuals with Alzheimer’s disease who have been treated with Cognition’s lead candidate, Elayta™.…
Sofia Fund Expands to Kansas City
Angel investment firm names McCoolidge managing partner
Minneapolis, MN, June 26, 2019 — Minneapolis-based Sofia Fund is expanding to the Kansas City market. To establish its presence in the area, which is a hub of startup activity, it has added a Kansas City-based partner, Laura McCoolidge.…
Steps to Success: Reasonable Valuations
Second blog in a series by Lisa Crump, founder of Cairn Ventures and Managing Partner, Sofia Fund. View Part I here. View Part III here.
Steps to Success incorporates advice and views in a short series of blogs, based on my experience as a tech entrepreneur and now angel investor, specifically focused on women-led startups.…
Cognition Therapeutics Appoints Anthony O. Caggiano M.D., Ph.D. to the Position of Chief Medical Officer
Pittsburgh, PA, June 05, 2019 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., today announced that Anthony O. Caggiano, M.D., Ph.D. has joined the Company as chief medical officer (CMO). Cognition Therapeutics is a clinical stage neuroscience company focused on the protection and restoration of synaptic function in Alzheimer’s disease and other neurodegenerative diseases and disorders caused by toxic oligomeric proteins.…
JoyLux Named Most Innovative Company of 2019 by Angel Capital Association
Winner of the prestigious Luis Villalobos Award, honoring ingenuity and innovation among start up companies.
Seattle, WA, April 25, 2019 — Joylux, a leading FemTech company using high-tech solutions to improve women’s intimate health, has been named the most innovative company by Angel Capital Association (ACA) members, a membership of 14,000+ accredited angel investors.…
Sofia Fund in national line-up of angel investors
How-to and resource list of top angel investors nationally, from FitSmallBusiness.com.
https://fitsmallbusiness.com/what-is-an-angel-investor/…